In vitro activity of micafungin against planktonic and sessile Candida albicans isolates

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2638-2639

  Jacobson, Melissa J ^a   Steckelberg, Kathryn E ^a   Piper, Kerryl E ^a   Steckelberg, James M ^a   Patel, Robin ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; MICAFUNGIN; VORICONAZOLE;

ABSCESS; ARTICLE; BIOFILM; BLOOD CULTURE; BONE; CANDIDA ALBICANS; CONTROLLED STUDY; DEVICE INFECTION; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERITONEAL FLUID; PLANKTON; PLEURA FLUID; PRIORITY JOURNAL; SESSILE SPECIES; SOFT TISSUE; URINE;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; ECHINOCANDINS; HUMANS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; PLANKTON;

EID: 67049086883     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01724-08     Document Type: Article

References (13)

1. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
2. Cateau, E., M. H. Rodier, and C. Imbert. 2008. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J. Antimicrob. Chemother. 62:153-155.
3. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183:5385-5394.
4. Choi, H. W., J. H. Shin, S. I. Jung, K. H. Park, D. Cho, S. J. Kee, M. G. Shin, S. P. Suh, and D. W. Ryang. 2007. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals. Antimicrob. Agents Chemother. 51:1520-1523.
5. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed. M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect. Immun. 62:915-921.
7. Jacobson, M. J., K. E. Piper, G. Nguyen, J. M. Steckelberg, and R. Patel. 2008. In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 52:2242-2243.
8. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
9. Laverdière, M., R. G. Lalonde, J. G. Baril, D. C. Sheppard, S. Park, and D. S. Perlin. 2006. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis. J. Antimicrob. Chemother. 57:705-708.
10. Mermel, L. A., B. M. Farr, R. J. Sherertz, I. I. Raad, N. O'Grady, J. S. Harris, and D. E. Craven. 2001. Guidelines for the management of intravascular catheter-related infections. Clin. Infect. Dis. 32:1249-1272.
11. Pfaller, M. A., L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2008. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J. Clin. Microbiol. 46:150-156.
12. Shuford, J. A., K. E. Piper, J. M. Steckelberg, and R. Patel. 2007. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn. Microbiol. Infect. Dis. 57:277-281. (Pubitemid 46330658)
13. Shuford, J. A., M. S. Rouse, K. E. Piper, J. M. Steckelberg, and R. Patel. 2006. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J. Infect. Dis. 194:710-713.